Market Recap — July 24, 2026
Recap of insider activity, SEC filings, and market-moving news for July 24, 2026.
Last generated Jul 25, 2026, 7:18 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
FDA Clears LYTENAVA as the First Ophthalmic Bevacizumab for Wet AMD
Nasdaq Moves to Delist FibroBiologics After Stock Fails $1 Bid Rule
Berkshire Hathaway Closes $8.5B Taylor Morrison Buyout; Delisting to Follow
FDA Approves LYTENAVA as First Ophthalmic Bevacizumab for Wet AMD
Powerdyne Registers 203M Shares for Toxic Equity Line and Warrant Amid Going Concern
MDxHealth Faces Second Nasdaq Deficiency, Now Failing Market Value Rule
Top KingWin Seeks Shareholder Nod for Sweeping Overhaul: 20x Share Expansion, Voting Power Concentration, Reverse Split, and Insider Incentive Plan
NYSE Delisting Notice Hits Surf Air Mobility After Sub-$1 Stock Price; Shareholders Approve Reverse Split
ISCO to Sell Core Subsidiary for $25M, Transforming into a Micro-Cap Biotech with $22M in Cash
Quantum-Si Faces Nasdaq Delisting Notice as Stock Sinks Below $1
INVO Fertility Registers Up to 20M Shares for $15M–$50M Dilutive Equity Line with Alumni Capital
NextEra Energy's S-4 goes effective, clearing the path for September shareholder votes on the Dominion merger
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
10% Owner Kenneth Dart Extends Accumulation Streak with $30.4M in Total Return Swaps
Director and 10% Owner Larry Allbaugh Buys $4.25M in FSBC Stock at Offering Price
10% Owner John Pasquesi Invests $1.77M in ClearSign Stock at $3.54 Per Share
10% Owner Opaleye Management Adds $1.57M to Alpha Cognition Stake, Total Holdings Near 3M Shares
Director Robert Perry-Smith Buys $1.38M in Five Star Bancorp Stock at Offering Price
Director and 10% Owner Choo Chee Kong Buys $300K More of CytoMed Therapeutics
CEO Sharon Carmel Buys $106K of Beamr Stock at $1.28
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
FDA Clears LYTENAVA as the First Ophthalmic Bevacizumab for Wet AMD
Nasdaq Moves to Delist FibroBiologics After Stock Fails $1 Bid Rule
Berkshire Hathaway Closes $8.5B Taylor Morrison Buyout; Delisting to Follow
FDA Approves LYTENAVA as First Ophthalmic Bevacizumab for Wet AMD
NYSE Delisting Notice Hits Surf Air Mobility After Sub-$1 Stock Price; Shareholders Approve Reverse Split
Quantum-Si Faces Nasdaq Delisting Notice as Stock Sinks Below $1
Cycurion Appeals Nasdaq Delisting; Hearing Set for August 2026
INVO Fertility Enters $15M–$50M Dilutive Equity Line, Authorizes 5x Share Increase Amid Going-Concern Crisis
Intel Beats Revenue by $1.7B, Posts Best Growth in 15 Years, Yet Stock Falls 11%
LiqTech Receives Nasdaq Delisting Warning — Stock Below $1 Minimum Bid
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.